Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Zydus to commercialize Vascular Endothelial Growth Factor inhibitor Nufymco in US

Cipla Secures Exclusive Rights to Sell Corex, Dolonex, Neksium, Dalacin C Under Pfizer Deal

Susmita Roy20 Dec 2025 6:30 PM IST

New Delhi: Cipla Limited has entered into a five-year exclusive supply and marketing agreement with Pfizer Products India Private Limited and Pfizer...

Alembic Pharma Moves Gujarat HC Against Rs 42.16 Crore Power Utility Invoices

Alembic Pharma Moves Gujarat HC Against Rs 42 Crore Power Utility Invoices

Susmita Roy20 Dec 2025 4:37 PM IST

New Delhi: Alembic Pharmaceuticals has approached the Gujarat High Court challenging supplementary invoices amounting to over Rs 42 crore issued by...

Misuse of ORS Label: FSSAI Issues 75 Notices to FBOs for Non-WHO Compliant Drinks

Susmita Roy20 Dec 2025 4:00 PM IST

Misuse of ORS Label:

Aurobindo Pharma Gets HC Relief in Compensation Cess Refund Dispute, GST Orders Quashed

Susmita Roy19 Dec 2025 3:15 PM IST

New Delhi: In a major relief to Aurobindo Pharma regarding the refund of compensation cess paid on coal used to manufacture medicines for export, the...

Generic Medicine Production Rises 26% to Rs 4.06 Lakh Cr in Three Years, Parliament Informed

Susmita Roy18 Dec 2025 3:32 PM IST

New Delhi: Despite the absence of separate production data for generic medicines, the total value of medicines produced in India surged by 26% over...

Vitamin D3 Tablets, Heparin Sodium Injection Fail Quality Test, 2 Drugmakers Blacklisted by CGMSC

Over 14,300 Drug Samples Fail Quality Tests in Five Years: Minister

Susmita Roy18 Dec 2025 2:55 PM IST

New Delhi: Over the last five years, drug regulators tested more than 4.9 lakh samples of medicines, including cough syrups, ORS, protein powders, and...

Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market

Novo Nordisk Gets CDSCO Panel Nod to Conduct India-Specific PMS Studies on Somapacitan

Susmita Roy17 Dec 2025 9:04 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Novo Nordisk India...

Health Ministry Proposes Perpetual Validity for Medical Device Licences

Susmita Roy17 Dec 2025 1:15 PM IST

New Delhi: Through a recent Gazette notification, the Ministry of Health and Family Welfare (Department of Health and Family Welfare) has issued a...

Diabetes Drug Bladder Cancer Risk Debate: Madras HC Orders Expert Review on Pioglitazone, Sitagliptin Safety

Susmita Roy16 Dec 2025 3:30 PM IST

New Delhi: The Madras High Court has directed the Union Ministry of Health and Family Welfare to constitute a team of medical experts to examine the...

NPPA Uses Pharma Sahi Daam App to Track Drug Price Violations, Parliament Informed

Susmita Roy16 Dec 2025 1:45 PM IST

New Delhi: Drug price violations are also tracked through NPPA's Pharma Sahi Daam mobile app, allowing consumers to check prices and lodge complaints,...

No More Court Trials for Pharma Firms in Minor Drug Law Violations

Parliamentary Panel Raps DoP, NPPA for 5-Year Delay in Trade Margin Rationalisation Under DPCO

Susmita Roy15 Dec 2025 8:30 PM IST

New Delhi: A parliamentary committee has expressed concern over the prolonged delay in formalizing a Trade Margin Rationalization (TMR) framework...

Wockhardt Gets Expert Panel Nod for Phase III Study of Recombinant Insulin Aspart

Susmita Roy15 Dec 2025 2:45 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting permission to...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok